AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 175 filers reported holding AMAG PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 2.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $194,000 | -59.0% | 25,400 | -34.7% | 0.00% | 0.0% |
Q4 2019 | $473,000 | -24.8% | 38,877 | -28.6% | 0.00% | -50.0% |
Q3 2019 | $629,000 | -37.8% | 54,433 | -46.3% | 0.01% | -40.0% |
Q2 2019 | $1,012,000 | -26.6% | 101,286 | -5.4% | 0.01% | -33.3% |
Q1 2019 | $1,379,000 | -36.3% | 107,036 | -24.9% | 0.02% | -40.0% |
Q4 2018 | $2,166,000 | +392.3% | 142,566 | +548.1% | 0.02% | +400.0% |
Q3 2018 | $440,000 | -65.7% | 21,998 | -66.6% | 0.01% | -70.6% |
Q2 2018 | $1,284,000 | -36.1% | 65,831 | -34.0% | 0.02% | -46.9% |
Q1 2018 | $2,010,000 | +518.5% | 99,749 | +306.6% | 0.03% | +433.3% |
Q4 2017 | $325,000 | -87.1% | 24,534 | -82.0% | 0.01% | -87.5% |
Q3 2017 | $2,512,000 | +148.0% | 136,133 | +367.6% | 0.05% | +17.1% |
Q4 2016 | $1,013,000 | +138.4% | 29,113 | +60.2% | 0.04% | +24.2% |
Q1 2016 | $425,000 | +42.1% | 18,170 | +83.5% | 0.03% | 0.0% |
Q4 2015 | $299,000 | +23.6% | 9,900 | +182.9% | 0.03% | -58.2% |
Q2 2015 | $242,000 | – | 3,500 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Camber Capital Management LP | 4,390,000 | $33,584,000 | 1.92% |
Bleichroeder LP | 1,299,994 | $9,945,000 | 1.76% |
ARMISTICE CAPITAL, LLC | 4,120,000 | $31,518,000 | 1.38% |
Palo Alto Investors LP | 2,959,587 | $22,641,000 | 1.36% |
Permanens Capital L.P. | 359,461 | $2,750,000 | 1.04% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 31,607 | $242,000 | 0.19% |
BOOTHBAY FUND MANAGEMENT, LLC | 348,000 | $2,662,000 | 0.18% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 795,611 | $6,086,000 | 0.07% |
Teza Capital Management LLC | 23,269 | $178,000 | 0.04% |
Livforsakringsbolaget Skandia, Omsesidigt | 38,800 | $297,000 | 0.03% |